Raymond P. Goodrich

1

Article

3

Comments
Development of vaccines typically takes several months and can be slowed by manufacturing requirements. PHILIPPE DESMAZES/AFP via Getty Images

Researchers seek to repurpose an existing manufacturing platform to produce a COVID‑19 vaccine

Alan Rudolph, Colorado State University and Raymond P. Goodrich, Colorado State University

In the search for a rapid COVID-19 vaccine, researchers are modifying a method using the chemical riboflavin now used to prevent disease transmission during blood transfusions.

Contact Raymond for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision
  • Location: Fort Collins, Colorado, The United States
  • Website
  • Article Feed
  • ORCID
  • Joined